カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のガバペンチンエナカルビル市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Gabapentin Enacarbil Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19340）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19340
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のガバペンチンエナカルビル市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ガバペンチンエナカルビル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のガバペンチンエナカルビルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ガバペンチンエナカルビル市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・カプセル、錠剤

用途別セグメントは次のように区分されます。
・帯状疱疹後神経痛（PHN）、むずむず脚症候群（RLS）、その他

世界のガバペンチンエナカルビル市場の主要な市場プレーヤーは以下のとおりです。
・Arbor Pharma、Astellas、GlaxoSmithKline、Glenmark Pharma、Pfizer、Depomed、Teva、Mylan、Novartis、Apotex、Sun Pharmaceutical、Aurobindo Pharma、Intas、Amneal、Marksans Pharma、Alkem、Jiangsu Enhua、Jiangsu Hengrui、Sailike Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ガバペンチンエナカルビル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なガバペンチンエナカルビルメーカーの企業概要、2019年～2022年までのガバペンチンエナカルビルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なガバペンチンエナカルビルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ガバペンチンエナカルビルの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのガバペンチンエナカルビルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのガバペンチンエナカルビル市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびガバペンチンエナカルビルの産業チェーンを掲載しています。
・第13、14、15章では、ガバペンチンエナカルビルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ガバペンチンエナカルビルの概要
- 種類別分析（2017年vs2021年vs2028年）：カプセル、錠剤
- 用途別分析（2017年vs2021年vs2028年）：帯状疱疹後神経痛（PHN）、むずむず脚症候群（RLS）、その他
- 世界のガバペンチンエナカルビル市場規模・予測
- 世界のガバペンチンエナカルビル生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Arbor Pharma、Astellas、GlaxoSmithKline、Glenmark Pharma、Pfizer、Depomed、Teva、Mylan、Novartis、Apotex、Sun Pharmaceutical、Aurobindo Pharma、Intas、Amneal、Marksans Pharma、Alkem、Jiangsu Enhua、Jiangsu Hengrui、Sailike Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：カプセル、錠剤
・用途別分析2017年-2028年：帯状疱疹後神経痛（PHN）、むずむず脚症候群（RLS）、その他
・ガバペンチンエナカルビルの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ガバペンチンエナカルビルのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ガバペンチンエナカルビルのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ガバペンチンエナカルビルの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ガバペンチンエナカルビルの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Gabapentin Enacarbil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gabapentin Enacarbil market size is estimated to be worth US$ 1586.6 million in 2021 and is forecast to a readjusted size of USD 1783.4 million by 2028 with a CAGR of 1.7% during review period. Post-Herpetic Neuralgia (PHN) accounting for % of the Gabapentin Enacarbil global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Capsule segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gabapentin Enacarbil include Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gabapentin Enacarbil market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsule
Tablet
Market segment by Application can be divided into
Post-Herpetic Neuralgia (PHN)
Restless Legs Syndrome (RLS)
Others
The key market players for global Gabapentin Enacarbil market are listed below:
Arbor Pharma
Astellas
GlaxoSmithKline
Glenmark Pharma
Pfizer
Depomed
Teva
Mylan
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gabapentin Enacarbil product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gabapentin Enacarbil, with price, sales, revenue and global market share of Gabapentin Enacarbil from 2019 to 2022.
Chapter 3, the Gabapentin Enacarbil competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin Enacarbil breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gabapentin Enacarbil market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gabapentin Enacarbil.
Chapter 13, 14, and 15, to describe Gabapentin Enacarbil sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Gabapentin Enacarbil Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gabapentin Enacarbil Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Gabapentin Enacarbil Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Post-Herpetic Neuralgia (PHN)
1.3.3 Restless Legs Syndrome (RLS)
1.3.4 Others
1.4 Global Gabapentin Enacarbil Market Size & Forecast
1.4.1 Global Gabapentin Enacarbil Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gabapentin Enacarbil Sales in Volume (2017-2028)
1.4.3 Global Gabapentin Enacarbil Price (2017-2028)
1.5 Global Gabapentin Enacarbil Production Capacity Analysis
1.5.1 Global Gabapentin Enacarbil Total Production Capacity (2017-2028)
1.5.2 Global Gabapentin Enacarbil Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gabapentin Enacarbil Market Drivers
1.6.2 Gabapentin Enacarbil Market Restraints
1.6.3 Gabapentin Enacarbil Trends Analysis
2 Manufacturers Profiles
2.1 Arbor Pharma
2.1.1 Arbor Pharma Details
2.1.2 Arbor Pharma Major Business
2.1.3 Arbor Pharma Gabapentin Enacarbil Product and Services
2.1.4 Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Astellas
2.2.1 Astellas Details
2.2.2 Astellas Major Business
2.2.3 Astellas Gabapentin Enacarbil Product and Services
2.2.4 Astellas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Gabapentin Enacarbil Product and Services
2.3.4 GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Glenmark Pharma
2.4.1 Glenmark Pharma Details
2.4.2 Glenmark Pharma Major Business
2.4.3 Glenmark Pharma Gabapentin Enacarbil Product and Services
2.4.4 Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Gabapentin Enacarbil Product and Services
2.5.4 Pfizer Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Depomed
2.6.1 Depomed Details
2.6.2 Depomed Major Business
2.6.3 Depomed Gabapentin Enacarbil Product and Services
2.6.4 Depomed Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Gabapentin Enacarbil Product and Services
2.7.4 Teva Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Gabapentin Enacarbil Product and Services
2.8.4 Mylan Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Gabapentin Enacarbil Product and Services
2.9.4 Novartis Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Apotex
2.10.1 Apotex Details
2.10.2 Apotex Major Business
2.10.3 Apotex Gabapentin Enacarbil Product and Services
2.10.4 Apotex Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sun Pharmaceutical
2.11.1 Sun Pharmaceutical Details
2.11.2 Sun Pharmaceutical Major Business
2.11.3 Sun Pharmaceutical Gabapentin Enacarbil Product and Services
2.11.4 Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Aurobindo Pharma
2.12.1 Aurobindo Pharma Details
2.12.2 Aurobindo Pharma Major Business
2.12.3 Aurobindo Pharma Gabapentin Enacarbil Product and Services
2.12.4 Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Intas
2.13.1 Intas Details
2.13.2 Intas Major Business
2.13.3 Intas Gabapentin Enacarbil Product and Services
2.13.4 Intas Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Amneal
2.14.1 Amneal Details
2.14.2 Amneal Major Business
2.14.3 Amneal Gabapentin Enacarbil Product and Services
2.14.4 Amneal Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Marksans Pharma
2.15.1 Marksans Pharma Details
2.15.2 Marksans Pharma Major Business
2.15.3 Marksans Pharma Gabapentin Enacarbil Product and Services
2.15.4 Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Alkem
2.16.1 Alkem Details
2.16.2 Alkem Major Business
2.16.3 Alkem Gabapentin Enacarbil Product and Services
2.16.4 Alkem Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Jiangsu Enhua
2.17.1 Jiangsu Enhua Details
2.17.2 Jiangsu Enhua Major Business
2.17.3 Jiangsu Enhua Gabapentin Enacarbil Product and Services
2.17.4 Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Jiangsu Hengrui
2.18.1 Jiangsu Hengrui Details
2.18.2 Jiangsu Hengrui Major Business
2.18.3 Jiangsu Hengrui Gabapentin Enacarbil Product and Services
2.18.4 Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Sailike Pharma
2.19.1 Sailike Pharma Details
2.19.2 Sailike Pharma Major Business
2.19.3 Sailike Pharma Gabapentin Enacarbil Product and Services
2.19.4 Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gabapentin Enacarbil Breakdown Data by Manufacturer
3.1 Global Gabapentin Enacarbil Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gabapentin Enacarbil Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gabapentin Enacarbil
3.4 Market Concentration Rate
3.4.1 Top 3 Gabapentin Enacarbil Manufacturer Market Share in 2021
3.4.2 Top 6 Gabapentin Enacarbil Manufacturer Market Share in 2021
3.5 Global Gabapentin Enacarbil Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gabapentin Enacarbil Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gabapentin Enacarbil Market Size by Region
4.1.1 Global Gabapentin Enacarbil Sales in Volume by Region (2017-2028)
4.1.2 Global Gabapentin Enacarbil Revenue by Region (2017-2028)
4.2 North America Gabapentin Enacarbil Revenue (2017-2028)
4.3 Europe Gabapentin Enacarbil Revenue (2017-2028)
4.4 Asia-Pacific Gabapentin Enacarbil Revenue (2017-2028)
4.5 South America Gabapentin Enacarbil Revenue (2017-2028)
4.6 Middle East and Africa Gabapentin Enacarbil Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gabapentin Enacarbil Sales in Volume by Type (2017-2028)
5.2 Global Gabapentin Enacarbil Revenue by Type (2017-2028)
5.3 Global Gabapentin Enacarbil Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gabapentin Enacarbil Sales in Volume by Application (2017-2028)
6.2 Global Gabapentin Enacarbil Revenue by Application (2017-2028)
6.3 Global Gabapentin Enacarbil Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gabapentin Enacarbil Sales by Type (2017-2028)
7.2 North America Gabapentin Enacarbil Sales by Application (2017-2028)
7.3 North America Gabapentin Enacarbil Market Size by Country
7.3.1 North America Gabapentin Enacarbil Sales in Volume by Country (2017-2028)
7.3.2 North America Gabapentin Enacarbil Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gabapentin Enacarbil Sales by Type (2017-2028)
8.2 Europe Gabapentin Enacarbil Sales by Application (2017-2028)
8.3 Europe Gabapentin Enacarbil Market Size by Country
8.3.1 Europe Gabapentin Enacarbil Sales in Volume by Country (2017-2028)
8.3.2 Europe Gabapentin Enacarbil Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gabapentin Enacarbil Sales by Type (2017-2028)
9.2 Asia-Pacific Gabapentin Enacarbil Sales by Application (2017-2028)
9.3 Asia-Pacific Gabapentin Enacarbil Market Size by Region
9.3.1 Asia-Pacific Gabapentin Enacarbil Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gabapentin Enacarbil Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gabapentin Enacarbil Sales by Type (2017-2028)
10.2 South America Gabapentin Enacarbil Sales by Application (2017-2028)
10.3 South America Gabapentin Enacarbil Market Size by Country
10.3.1 South America Gabapentin Enacarbil Sales in Volume by Country (2017-2028)
10.3.2 South America Gabapentin Enacarbil Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gabapentin Enacarbil Sales by Type (2017-2028)
11.2 Middle East & Africa Gabapentin Enacarbil Sales by Application (2017-2028)
11.3 Middle East & Africa Gabapentin Enacarbil Market Size by Country
11.3.1 Middle East & Africa Gabapentin Enacarbil Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gabapentin Enacarbil Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gabapentin Enacarbil and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gabapentin Enacarbil
12.3 Gabapentin Enacarbil Production Process
12.4 Gabapentin Enacarbil Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gabapentin Enacarbil Typical Distributors
13.3 Gabapentin Enacarbil Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Gabapentin Enacarbil Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gabapentin Enacarbil Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Arbor Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Arbor Pharma Major Business
Table 5. Arbor Pharma Gabapentin Enacarbil Product and Services
Table 6. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Astellas Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Major Business
Table 9. Astellas Gabapentin Enacarbil Product and Services
Table 10. Astellas Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Gabapentin Enacarbil Product and Services
Table 14. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Glenmark Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Glenmark Pharma Major Business
Table 17. Glenmark Pharma Gabapentin Enacarbil Product and Services
Table 18. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Gabapentin Enacarbil Product and Services
Table 22. Pfizer Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Depomed Basic Information, Manufacturing Base and Competitors
Table 24. Depomed Major Business
Table 25. Depomed Gabapentin Enacarbil Product and Services
Table 26. Depomed Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Teva Basic Information, Manufacturing Base and Competitors
Table 28. Teva Major Business
Table 29. Teva Gabapentin Enacarbil Product and Services
Table 30. Teva Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Gabapentin Enacarbil Product and Services
Table 34. Mylan Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novartis Basic Information, Manufacturing Base and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Gabapentin Enacarbil Product and Services
Table 38. Novartis Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Apotex Basic Information, Manufacturing Base and Competitors
Table 40. Apotex Major Business
Table 41. Apotex Gabapentin Enacarbil Product and Services
Table 42. Apotex Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Major Business
Table 45. Sun Pharmaceutical Gabapentin Enacarbil Product and Services
Table 46. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Aurobindo Pharma Major Business
Table 49. Aurobindo Pharma Gabapentin Enacarbil Product and Services
Table 50. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Intas Basic Information, Manufacturing Base and Competitors
Table 52. Intas Major Business
Table 53. Intas Gabapentin Enacarbil Product and Services
Table 54. Intas Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Amneal Basic Information, Manufacturing Base and Competitors
Table 56. Amneal Major Business
Table 57. Amneal Gabapentin Enacarbil Product and Services
Table 58. Amneal Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Marksans Pharma Major Business
Table 61. Marksans Pharma Gabapentin Enacarbil Product and Services
Table 62. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Alkem Basic Information, Manufacturing Base and Competitors
Table 64. Alkem Major Business
Table 65. Alkem Gabapentin Enacarbil Product and Services
Table 66. Alkem Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Jiangsu Enhua Basic Information, Manufacturing Base and Competitors
Table 68. Jiangsu Enhua Major Business
Table 69. Jiangsu Enhua Gabapentin Enacarbil Product and Services
Table 70. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 72. Jiangsu Hengrui Major Business
Table 73. Jiangsu Hengrui Gabapentin Enacarbil Product and Services
Table 74. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Sailike Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Sailike Pharma Major Business
Table 77. Sailike Pharma Gabapentin Enacarbil Product and Services
Table 78. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Gabapentin Enacarbil Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 80. Global Gabapentin Enacarbil Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Gabapentin Enacarbil, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Gabapentin Enacarbil Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Gabapentin Enacarbil Production Site of Key Manufacturer
Table 84. Gabapentin Enacarbil New Entrant and Capacity Expansion Plans
Table 85. Gabapentin Enacarbil Mergers & Acquisitions in the Past Five Years
Table 86. Global Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units)
Table 87. Global Gabapentin Enacarbil Sales by Region (2023-2028) & (K Units)
Table 88. Global Gabapentin Enacarbil Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Gabapentin Enacarbil Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 91. Global Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 92. Global Gabapentin Enacarbil Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Gabapentin Enacarbil Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Gabapentin Enacarbil Price by Type (2017-2022) & (US$/Unit)
Table 95. Global Gabapentin Enacarbil Price by Type (2023-2028) & (US$/Unit)
Table 96. Global Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 97. Global Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 98. Global Gabapentin Enacarbil Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Gabapentin Enacarbil Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Gabapentin Enacarbil Price by Application (2017-2022) & (US$/Unit)
Table 101. Global Gabapentin Enacarbil Price by Application (2023-2028) & (US$/Unit)
Table 102. North America Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
Table 103. North America Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units)
Table 104. North America Gabapentin Enacarbil Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Gabapentin Enacarbil Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 107. North America Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 108. North America Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 109. North America Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 110. Europe Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
Table 111. Europe Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units)
Table 112. Europe Gabapentin Enacarbil Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Gabapentin Enacarbil Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 115. Europe Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 116. Europe Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 117. Europe Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 118. Asia-Pacific Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Gabapentin Enacarbil Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Gabapentin Enacarbil Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Gabapentin Enacarbil Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 124. Asia-Pacific Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 125. Asia-Pacific Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 126. South America Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
Table 127. South America Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units)
Table 128. South America Gabapentin Enacarbil Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Gabapentin Enacarbil Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 131. South America Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 132. South America Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 133. South America Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 134. Middle East & Africa Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units)
Table 135. Middle East & Africa Gabapentin Enacarbil Sales by Region (2023-2028) & (K Units)
Table 136. Middle East & Africa Gabapentin Enacarbil Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Gabapentin Enacarbil Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
Table 139. Middle East & Africa Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units)
Table 140. Middle East & Africa Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
Table 141. Middle East & Africa Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units)
Table 142. Gabapentin Enacarbil Raw Material
Table 143. Key Manufacturers of Gabapentin Enacarbil Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Gabapentin Enacarbil Typical Distributors
Table 147. Gabapentin Enacarbil Typical Customers
List of Figures
Figure 1. Gabapentin Enacarbil Picture
Figure 2. Global Gabapentin Enacarbil Revenue Market Share by Type in 2021
Figure 3. Capsule
Figure 4. Tablet
Figure 5. Global Gabapentin Enacarbil Revenue Market Share by Application in 2021
Figure 6. Post-Herpetic Neuralgia (PHN)
Figure 7. Restless Legs Syndrome (RLS)
Figure 8. Others
Figure 9. Global Gabapentin Enacarbil Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Gabapentin Enacarbil Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Gabapentin Enacarbil Sales (2017-2028) & (K Units)
Figure 12. Global Gabapentin Enacarbil Price (2017-2028) & (US$/Unit)
Figure 13. Global Gabapentin Enacarbil Production Capacity (2017-2028) & (K Units)
Figure 14. Global Gabapentin Enacarbil Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Gabapentin Enacarbil Market Drivers
Figure 16. Gabapentin Enacarbil Market Restraints
Figure 17. Gabapentin Enacarbil Market Trends
Figure 18. Global Gabapentin Enacarbil Sales Market Share by Manufacturer in 2021
Figure 19. Global Gabapentin Enacarbil Revenue Market Share by Manufacturer in 2021
Figure 20. Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Gabapentin Enacarbil Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Gabapentin Enacarbil Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Gabapentin Enacarbil Sales Market Share by Region (2017-2028)
Figure 24. Global Gabapentin Enacarbil Revenue Market Share by Region (2017-2028)
Figure 25. North America Gabapentin Enacarbil Revenue (2017-2028) & (USD Million)
Figure 26. Europe Gabapentin Enacarbil Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Gabapentin Enacarbil Revenue (2017-2028) & (USD Million)
Figure 28. South America Gabapentin Enacarbil Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Gabapentin Enacarbil Revenue (2017-2028) & (USD Million)
Figure 30. Global Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 31. Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2028)
Figure 32. Global Gabapentin Enacarbil Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 34. Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2028)
Figure 35. Global Gabapentin Enacarbil Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 37. North America Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 38. North America Gabapentin Enacarbil Sales Market Share by Country (2017-2028)
Figure 39. North America Gabapentin Enacarbil Revenue Market Share by Country (2017-2028)
Figure 40. United States Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 44. Europe Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 45. Europe Gabapentin Enacarbil Sales Market Share by Country (2017-2028)
Figure 46. Europe Gabapentin Enacarbil Revenue Market Share by Country (2017-2028)
Figure 47. Germany Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Gabapentin Enacarbil Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Gabapentin Enacarbil Revenue Market Share by Region (2017-2028)
Figure 56. China Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 63. South America Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 64. South America Gabapentin Enacarbil Sales Market Share by Country (2017-2028)
Figure 65. South America Gabapentin Enacarbil Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Gabapentin Enacarbil Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Gabapentin Enacarbil in 2021
Figure 77. Manufacturing Process Analysis of Gabapentin Enacarbil
Figure 78. Gabapentin Enacarbil Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用L-グルタミン市場2022年：市場規模予測（～2028年）
  • 世界のオキサゾラム市場2022年：市場規模予測（～2028年）
  • 世界のレナリドミドカプセル市場2022年：市場規模予測（～2028年）
  • 世界のマレヴァン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用タブレットプレス市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19340 )"世界のガバペンチンエナカルビル市場2022年：市場規模予測（～2028年）" (英文：Global Gabapentin Enacarbil Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。